"The Association Between Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) and Suicidality: Reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)." Expert Opinion on Drug Safety, 13 Dec
"ALCAR and depressive symptoms: systematic review and meta-analysis." Psychosom Med 2018;80:154-9
Eligible publications were limited to articles and reviews written in English and published between 2020 and 2025
Belle works with four pharmacies: BPI Labs (Largo, FL), VitalRx Pharmacy (Pearland, TX), The Pharmacy Hub (Miami, FL), and Olympia Pharmaceuticals (Orlando, FL)
Retatrutide is a more recently developed triple agonist peptide, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously